Text Size: AAA

Expanding Research Initiatives

We encourage investigation of new and innovative ways to treat eye disease. To aid in this effort, Santen offers grants to qualifying applicants for Investigator Sponsored Trials (ISTs). To apply, click the link below.

What is the IST program?

An IST is typically conducted by a clinician or scientist, known as a Sponsor Investigator (SI), or an academic institution to pursue scientific discovery and innovation during the development and post-approval periods of a pharmaceutical agent.

Through this program, Santen provides IST grants to support research in the following therapeutic areas:

  • Back of the eye (Retinal disorders, Uveitis)
  • Glaucoma
  • Front of the eye (Anterior segment disorders, Dry eye)
  • Specific portfolio compounds or products of interest

Evaluation process

  • To be considered, all applicants must provide comprehensive study details, such as scientific rationale, primary/secondary objectives, study endpoints, projected study design, and fair market study budget
  • Study proposals will be reviewed for scientific merit, validity, and alignment with Santen's scientific research and business strategies
  • Qualified applicants will be notified of decisions and given feedback, as appropriate
  • Accepted and approved proposals will begin the IST clinical research process in adherence to industry and local guidelines and regulations.

This portal is for IST applications involving the following products ONLY: DE-109 (Opsiria TM), DE-117, DE-120, DE-122, Ikervis, Vekacia, Cationorm, Diquas, Tafluprost family and MIGS. To submit an IST for another product/compound, please contact your regional Santen Medical Affairs representative. Investigators from Japan, please contact your regional Santen representative for ALL IST submissions. For further questions, please call +1-415-268-9100.

Begin Application Here

Thank you for visiting Santen USA

Click continue to be redirected to Santen Worldwide at www.santen.com